Journal of Virology · 2021 · 47 citations · 42 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesVaccine ImmunologyVaccinologyBooster ImmunizationVaccinationVaccination SchedulesVaccine DevelopmentVaccine EfficacyVaccine SafetyBooster Dose EffectivenessBooster Dose EfficacyBooster Vaccine EfficacyBooster Vaccine ImmunogenicityEquitable Vaccine DistributionHerd Immunity AssessmentHerd Immunity ModelingVaccine Effectiveness After Boosting
Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants has led to increases in breakthrough infections, prompting consideration for vaccine booster doses. Boosters have been reported to be safe and increase SARS-CoV-2-specific neutralizing antibody levels, but how these doses impact the trajectory of the global pandemic and herd immunity is unknown. Information on immunology, epidemiology, and equitable vaccine distribution should be considered when deciding the timing and eligibility for COVID-19 vaccine boosters.
42
The Mathematics of Infectious Diseases
Herbert W. Hethcote · SIAM Review · 2000 · 6.9K citations
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato et al. · Science · 2021 · 3K citations · Full text
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Yinon M. Bar‐On, Yair Goldberg, Micha Mandel et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text